Acesion Pharma Announces Positive Results for Novel Drug Targeting Atrial Fibrillation
Acesion Pharma (“Acesion” or the Company), a Danish biotech company developing novel treatments for atrial fibrillation (AF), the most...
top of page
- Mar 12, 2018
- 2 min
Acesion Pharma Commences Phase 1 Study in Atrial Fibrillation
Acesion Pharma (“Acesion” or the Company), a Danish biotech company developing novel treatments for atrial fibrillation (AF), the most...
92 views
- Feb 8, 2018
- 2 min
Acesion Pharma Receives Approval for Phase I Study in Atrial Fibrillation
Acesion Pharma (“Acesion” or the Company), a Danish biotech company developing novel treatments for atrial fibrillation (AF), the most...
75 views
LATEST NEWS
bottom of page